跳至主要内容
临床试验/NCT04566250
NCT04566250已完成不适用

Non-Opioid Prescriptions After Arthroscopic Surgery in Canada (NO PAin): a Randomized Controlled Trial

McMaster University6 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年2月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
6
主要终点
Total oral morphine equivalents (OMEs)

研究概览

简要总结

This is a randomized controlled trial of 200 patients between the ages of 18 and 65 years undergoing outpatient knee or shoulder arthroscopy. Patients will be evaluated clinically at 2 and 6 weeks post-operatively. Patients will be recruited from experienced arthroscopic surgeons at 3 hospital sites in Hamilton, Ontario. All research will be conducted according to international standards of Good Clinical Practice and institutional research policies and procedures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Given that patients in the intervention group will receive a pamphlet explaining how to use their prescription allocation, patient blinding is not feasible. Surgeons cannot be blinded as they will need to sign the prescriptions and provide any necessary advice about the medications being prescribed. Outcome assessors and data analysts will be blinded.

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing outpatient knee or shoulder arthroscopy for any of the following procedures: ACL reconstruction (with or without LET), MPFL reconstruction (not including TTO), Chondroplasty, Meniscectomy, Meniscal repair Meniscal transplant, Microfracture, ACI, Fixation of unstable osteochondral lesion, Subacromial decompression, Rotator cuff repair, Shoulder stabilization, Superior capsule reconstruction, Biceps tenotomy/tenodesis, Capsular release, SLAP repair, Diagnostic arthroscopy, Irrigation and/or debridement, Loose body removal, Synovectomy
  • Patients aged 18 years and older
  • Patients who have the ability to speak, understand, and read English
  • Provision of informed consent

排除标准

  • Patients who take or are on a home dose of an opioid medication (i.e. once daily or more)
  • Patients involved in ongoing litigation or compensation claims for any injury (e.g. Work Safety Insurance Board, WSIB)
  • Patients involved in another research study that requires a specific post-operative pain control medication regimen
  • Patients undergoing a knee or shoulder arthroscopy procedure that will likely have an operative time greater than 3 hours
  • Patients who will undergo concomitant open surgery
  • Patients who require overnight admission
  • Patients with a contraindication or allergy to NSAIDs, acetaminophen, or morphine and hydromorphone
  • Patients diagnosed with renal disease or cardiac disease
  • Patients who are scheduled for/plan to have an additional surgical procedure during the 6-week follow-up period
  • Patients who will likely have problems, in the judgement of the investigator, with maintaining follow-up
  • Any other reason(s) the investigator feels is relevant for excluding the patient

结局指标

主要结局

Total oral morphine equivalents (OMEs)

时间窗: 6 weeks postoperatively

The primary outcome is the number of total OMEs consumed as determined by a patient-reported medication diary.

次要结局

  • Opioid Refills(6 weeks postoperatively)
  • OMEs Prescribed(6 weeks postoperatively)
  • Adverse Events(6 weeks postoperatively)
  • Patient Satisfaction (Hospital Consumer Assessment of Health Care Provider and Systems Question, HCAHPS)(6 weeks postoperatively)
  • Pain (Visual Analogue Scale, VAS)(6 weeks postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Olufemi Ayeni

Professor

McMaster University

研究点 (6)

Loading locations...

相似试验